Success Stories: In a Short Period of 3 Months, NIW Approval Confirmed for a Taiwanese Postdoctoral Associate in Neuroscience, Thanks to our Teamwork

 

Client’s Testimonial:

“Thanks a lot for the help with the case filing.”

---

On January 19^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Neuroscience (Approval Notice).

---

General Field: Neuroscience

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Taiwan

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: January 19^th, 2023

Processing Time: 3 months

---

Case Summary:

As an expert in the field of neuroscience, our NIW (National Interest Waiver) client’s proposed endeavor is to continue her research on developing novel therapies for neurodegenerative diseases and improving therapeutic outcomes by employing advanced electrophysiological and genetic manipulation techniques in order to uncover neurodegenerative mechanisms. In order to prove her worth to the national and international scientific community, our team made a database of her academic and professional accomplishments, some of which are as follows:

• Her research advancing her proposed endeavor is of great importance because it advances knowledge of the mechanisms of neurodegenerative diseases.
• Neurodegenerative diseases are one class of neurological disorders that impact up to a billion people each year, and from which an estimated 6.8 million die annually, and our client has researched the genetic mechanisms leading to several of those neurodegenerative diseases, including Huntington’s disease.
• Her proposed endeavor also has broad implications for the United States in that it advances diagnostics and therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease, which afflict millions of Americans annually.
• Due to its clear national importance, her research has in fact been supported with funding from the National Institutes of Health (NIH).
• Her research has resulted in 9 peer-reviewed journal articles (3 of them first-authored) and they have been cited a total of 108 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of neuroscience.
• She has also pursued research directly related to her proposed endeavor of employing advanced electrophysiological and genetic manipulation techniques to uncover neurodegenerative mechanisms, utilizing her extensive experience with electrophysiology, calcium imaging, behavioral tests, and genetic engineering for 7 years.
• Finally, she had been able to collect 4 letters of recommendation from other experts in the field of which one said:

“Our understanding of proper neuropeptide release has been greatly enhanced by [the client’s] research into genes and their regulatory functions, and this is contributing to the creation of more accurately targeted therapeutic treatments for neurodegenerative disorders…common neurological disease including Alzheimer's and other dementias cost the United States nearly $800 billion each year in healthcare costs and lost productivity. Considering the contributions [the client] has already made towards the mitigation of these illnesses, it is my position that the continuation of her research in the United States is of significant benefit to both the physical and economic health of those in the nation.”

These arguments helped us win the case in a short period of 3 months. We are proud of having helped her in this process and we wish her all the best in her future endeavors.

---